English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

We report a case in which combination therapy with albumin-bound paclitaxel (nab-paclitaxel) and gemcitabine converted unresectable pancreatic cancer with peritoneal metastases into resectable disease. The patient was a 71-year-old woman with anorexia. Enhanced abdominal computed tomography (CT) showed an atrophic pancreatic body and tail, dilated main pancreatic duct, peritoneal dissemination, portal vein stricture, bile duct stricture and wall thickening, and blockage of the right ureter. She was diagnosed with pancreatic cancer with peritoneal metastases. Curative resection was initially impossible. Combination therapy consisting of nab-paclitaxel and gemcitabine was initiated. The regimen consisted of 28-day cycles of albumin-bound paclitaxel (nab-paclitaxel) (125 mg/m 2 intravenously over 30 min on days 1, 8, 15) and gemcitabine (1000 mg/m 2 intravenously over 30 min on days 1, 8, 15). After 8 cycles of chemotherapy, enhanced CT showed no evidence of the tumor in the pancreatic body and tail or peritoneal metastases. Positron emission tomography with CT (PET-CT) showed no abnormal fluorodeoxyglucose uptake. After pre-operative chemotherapy for 8 months, the patient was underwent distal pancreatectomy with resection of soft tissue that corresponded to the right ureteral tumor seen on enhanced CT. This case showed that chemotherapy consisting of nab-paclitaxel and gemcitabine can be well-tolerated and can convert unresectable pancreatic cancer with peritoneal metastases into resectable disease.

international cancer conference journal

Successful conversion surgery for unresectable pancreatic cancer with peritoneal metastases after neoadjuvant albumin-bound paclitaxel and gemcitabine chemotherapy: case report and literature review